Ad is loading...
AFCMX
Price
$16.65
Change
-$0.29 (-1.71%)
Updated
Nov 15 closing price
RERAX
Price
$53.01
Change
-$0.52 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

AFCMX vs RERAX

Header iconAFCMX vs RERAX Comparison
Open Charts AFCMX vs RERAXBanner chart's image
American Century Focused Intl Gr R6
Price$16.65
Change-$0.29 (-1.71%)
VolumeN/A
CapitalizationN/A
American Funds Europacific Growth R1
Price$53.01
Change-$0.52 (-0.97%)
VolumeN/A
CapitalizationN/A
AFCMX vs RERAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AFCMX vs. RERAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFCMX is a Sell and RERAX is a Buy.

FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 129B vs. AFCMX (105M). RERAX pays higher dividends than AFCMX: RERAX (0.91) vs AFCMX (0.64). AFCMX was incepted earlier than RERAX: AFCMX (9 years) vs RERAX (22 years). AFCMX is a more actively managed with annual turnover of: 61.00 vs. RERAX (34.00). AFCMX has a lower initial minimum investment than RERAX: AFCMX (0) vs RERAX (250). AFCMX annual gain was more profitable for investors over the last year : 11.86 vs. RERAX (7.63). AFCMX return over 5 years is better than : 18.72 vs. RERAX (3.85).
AFCMXRERAXAFCMX / RERAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years22 years-
Gain YTD4.3233.052142%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets105M129B0%
Annual Yield % from dividends0.640.9170%
Returns for 1 year11.867.63155%
Returns for 3 years-20.78-19.45107%
Returns for 5 years18.723.85486%
Returns for 10 yearsN/A15.89-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APP291.096.60
+2.32%
Applovin Corp
BBDC9.950.06
+0.61%
Barings BDC
SIF3.60N/A
N/A
SIFCO Industries
CNS100.47-0.25
-0.25%
Cohen & Steers
FATE2.02-0.06
-2.88%
Fate Therapeutics